Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Flammable Medical Cleaning Agent Supply

Active

Federal

Response Deadline08/10/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires the supply of a specific FDA-regulated, flammable medical cleaning agent identified by NSN 6505-01-654-9628, with strict adherence to HAZMAT-compliant handling procedures throughout procurement, storage, and delivery. An EBS referral confirmation is mandatory prior to fulfilling the order, ensuring proper authorization and regulatory alignment for this hazardous material. The solicitation is structured as a subcontract under the Department of Defense, managed by the Medical Supply Chain Pharm FSA, with performance required at JBER, Alaska, ZIP 99506-4400. The NAICS code 325992 indicates classification within other chemical product and preparation manufacturing, and all responses must be submitted by the deadline of August 10, 2026, with the opportunity posted on August 2, 2026. Compliance with federal safety and transportation standards for flammable substances is non-negotiable, and failure to meet these requirements will result in disqualification.

General Info

Supply FDA-regulated flammable medical cleaner per HAZMAT rules, EBS confirmation required, delivery to JBER Alaska by August 10, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325992 - Photographic Film, Paper, Plate, Chemical, and Copy Toner ManufacturingView NAICS

Place of Performance

JBER, AK, 99506-4400, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 2

subcontract

Response DeadlineAug 10

Submission deadline

Response Deadline

08/10/2026, 05:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply a specific FDA-regulated, flammable medical cleaning agent (NSN 6505-01-654-9628), requiring EBS referral confirmation and HAZMAT-compliant handling.

Similar Contracts

Same NAICS industry code

Brand Name Only Toners for DLA Distribution

Solicitation # SP330026Q5005

This contract establishes a single-award, indefinite delivery indefinite quantity (IDIQ) agreement for the procurement of new, never-used, brand-name-only toner cartridges compatible with printers from approved manufacturers including Konica Minolta, Kyocera, Ricoh, Hewlett Packard, Lexmark, and Xerox. The contract is structured as a fixed-price vehicle with firm fixed-price delivery orders, covering five sequential one-year ordering periods from September 28, 2026, through September 27, 2031. All items must be original equipment manufacturer (OEM) products, and re-manufactured, re-furbished, or clone cartridges are strictly prohibited. Deliveries must meet strict performance standards, ensuring no printer jams, delays, or damage, and all products must comply with the detailed specifications outlined in Attachment 01, the Schedule of Supplies, which lists over seventy contract line item numbers (CLINs). The contract requires full supply chain traceability, mandating documentation that verifies the origin and authenticity of each cartridge from manufacturer to government acceptance, and prohibits the use of additive manufacturing unless explicitly authorized. The solicitation is a total small business set-aside under NAICS code 325992 with a size standard of 1,500 employees, and all offerors must certify their small business status. Quotations must be submitted electronically via email by August 7, 2026, and are evaluated under a pass/fail technical and past performance regime, with award going to the lowest-priced acceptable offeror under FAR Part 12. Each quotation must be organized into three separate files covering technical capability, past performance, and pricing with administrative data. Packaging and shipping must conform to ASTM D3951-10 and MIL-STD-129R/P standards, with all shipments marked with required identifying data including contract number, delivery order number, stock number, and unit of issue. Invoicing and payment must be processed through the Wide Area Workflow (WAWF) system, and all items are delivered FOB destination. Contractors are subject to Buy American requirements, cybersecurity compliance under NIST SP 800-171, and restrictions on the use of fluorinated firefighting agents, and must represent their compliance with SAM, CUI, and exclusion screening requirements. The contract includes numerous incorporated clauses from FAR, DFARS, and DLA directives governing pricing, modifications, subcontracting, transportation, security, and representation,

DLA Distribution

POSTED

about 19 hours ago

DEADLINE

Supply of Aircraft Turbine Engine Lubricating OilThe contract requires the procurement and delivery of 82 quarts of military-spec lubricating oil designated by NSN 915002732388 to the USS GEORGE H.W. BUSH (CVN 77) located in Norfolk, Virginia, with a firm delivery deadline of August 17, 2026. The lubricant must fully comply with applicable military performance specifications or original equipment manufacturer standards, ensuring compatibility and operational safety for aircraft turbine engines. All packaging, labeling, and accompanying documentation must meet strict regulatory requirements to guarantee traceability and conformity. The transaction is structured as a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and falls under the NAICS code 325992 for other chemical product and preparation manufacturing. The delivery must be executed without delay to support fleet readiness, and all invoicing must align with the precise contractual terms to facilitate timely payment and compliance verification.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Gram Staining Kit ComponentsThe contract involves the manufacture and supply of critical chemical reagents for Gram Staining Kits, specifically Crystal Violet Stain, Iodine Solution, Alcohol as a decolorizer, and Safranin Stain, all of which must meet stringent quality and regulatory standards. Each batch of reagents requires full traceability to ensure consistency, purity, and compliance with applicable medical and laboratory protocols, with documentation supporting every stage of production and delivery. The components are intended for use in diagnostic and clinical environments under the authority of the Department of Defense’s Medical Supply Chain. This is a subcontract solicitation posted on August 2, 2026, with responses due by August 10, 2026, under NAICS code 325992 for other chemical product and preparation manufacturing. The place of performance is designated as FPO with ZIP code 96661, indicating delivery to military medical facilities operating in overseas or expeditionary settings. The agreement is managed under the agency designation MEDICAL SUPPLY CHAIN MD SURG FSF, and suppliers must ensure adherence to defense-specific logistical, quality, and regulatory requirements without exception, especially concerning the handling, labeling, and shipping of hazardous chemicals in compliance with military supply chain protocols.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

NSN Item Supply / ManufacturingThe contract pertains to the supply or manufacture of NSN 4820012839425, a hazardous fire suppression agent, requiring strict adherence to Department of Defense specifications and delivery protocols. The item is classified under NAICS code 325992, indicating it falls within other chemical product and preparation manufacturing, and is being procured as a subcontract under the Defense Logistics Agency, a division of the Department of Defense. The solicitation was posted on August 2, 2026, with a response deadline of August 13, 2026, and the place of performance is designated as FPO, ZIP 96643, indicating delivery to a military postal location, likely supporting overseas or deployed operations. Compliance with all federal and DoD regulatory standards for hazardous materials handling, packaging, and transportation is mandatory, and the contractor must ensure the product meets exact performance, safety, and quality benchmarks required for military use.

Defense Logistics Agency

POSTED

DEADLINE

Medical Packaging and Labeling ServicesThe contract requires comprehensive packaging, labeling, and marking services for medical items in full compliance with Defense Logistics Agency standards, emphasizing traceability, lot control, and adherence to all applicable regulatory requirements. All work must be performed to ensure medical supplies are properly identified, documented, and prepared for distribution within the Department of Defense supply chain, with strict attention to accuracy and accountability at every stage. The solicitation is classified as a subcontract under NAICS code 325992, with a response deadline of August 10, 2026, and a posting date of August 2, 2026. Performance is specifically mandated to occur at Quantico, Virginia, with a zip code of 22134-6062. The contracting organization is the Medical Supply Chain MD Surg FSF under the Department of Defense, and all activities must align with DLA protocols to support military medical readiness and operational logistics needs.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Device Packaging and Labeling ServicesThe contract requires commercial packaging and labeling of chest drain units in strict compliance with Medical Marking Standard No. 1, ensuring all units are properly marked with expiration date, lot number, contract number, and manufacturer date. The work must be performed according to federal medical device labeling requirements and is intended for deployment through military supply channels, with performance taking place at the APO location designated by the Department of Defense. This subcontract falls under NAICS code 325992, indicating it involves other miscellaneous chemical product and preparation manufacturing, and is part of the Medical Supply Chain’s Medical Surgical Financial Services initiative. Bids must be submitted by August 10, 2026, and the opportunity was posted on August 2, 2026, with all relevant details accessible through the DIBBS RFQ platform.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Aviation Fuel Icing Inhibitor ChemicalThe contract covers the manufacture or supply of 44,000 units of aviation fuel icing inhibitor identified by NSN 6850010576427, ensuring full compliance with applicable military specifications for performance and quality. The product is destined for delivery to Qatar under a subcontract awarded by the Defense Logistics Agency, a component of the Department of Defense, with the North American Industry Classification System code 325992 indicating the industrial category for other chemical product and preparation manufacturing. The solicitation was posted on August 2, 2026, and the place of performance is not specified, but the end-use location is clearly Qatar, underscoring the international nature of the supply requirement. The contract is linked to a DIBBS award record, confirming its formal issuance and tracking under the U.S. military logistics system, with no set-aside provisions identified, indicating it is open to any qualified supplier.

Defense Logistics Agency

POSTED

DEADLINE

Medical Packaging and Labeling ServicesThe contract requires the packaging and labeling of tourniquets in sealed units that meet strict compliance standards including MMS No. 1, ASTM D3951, and DLA RP001, ensuring suitability for military medical supply chain deployment. Each unit must be properly barcoded for tracking and include hazardous material labeling as required by applicable regulations, with all processes designed to maintain integrity and traceability throughout storage and distribution. The work must be performed to support the Department of Defense’s Medical Supply Chain, specifically under the MEDICAL SUPPLY CHAIN MD SURG FSF, with performance centered at Fort Lewis, Washington, ZIP 98433-9500. Subcontractors must respond by the deadline of August 10, 2026, and the solicitation falls under NAICS code 325992 for other pharmaceutical and medicinal product manufacturing. All packaging procedures must align with military logistics and safety protocols without exception.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Packaging & Shelf-Life ComplianceThe contract requires the provision of pharmaceutical packaging in sealed unit containers that fully comply with MIL-STD-2073-1E standards to ensure product integrity, environmental protection, and extended shelf-life of 36 months under controlled storage conditions of 25°C. The packaging must maintain the stability and safety of the pharmaceutical products throughout storage and distribution, meeting all military specifications for preservation, labeling, and environmental resistance. Compliance with these rigorous standards is mandatory to support reliable logistics and operational readiness. The solicitation is categorized as a subcontract under NAICS code 325992 and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. Interested parties must submit responses by the deadline of August 10, 2026, with the opportunity posted on August 2, 2026. The work is tied to a specific government logistics and supply chain function, and successful bidders will be expected to deliver packaging solutions that guarantee long-term performance under defined environmental parameters without reliance on additional protective measures. All deliverables must be traceable, consistent, and fully aligned with defense-grade packaging protocols.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Labeling & Medical Marking ComplianceThe contract requires precise compliance with Medical Marking Standard No. 1 for the labeling and marking of pharmaceutical packaging, ensuring all content, format, and durability meet stringent standards set by the Defense Logistics Agency and the Food and Drug Administration. The work involves applying permanent, legible, and tamper-resistant markings that adhere to regulatory specifications for identification, traceability, and safety throughout the supply chain, with attention to material resilience under varied environmental conditions. All labeling must be accurate, fully compliant, and consistently applied across all packaged pharmaceutical items intended for military and government use. The contract is classified as a subcontract under NAICS code 325992 and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on August 2, 2026, with a firm response deadline of August 10, 2026. The place of performance and point of contact details are not specified, but performance is expected to support federal healthcare and logistics operations under DLA oversight. The procurement is open to qualified subcontractors capable of delivering fully auditable, compliant labeling solutions without deviation from established standards, and all submissions must align with the requirements enumerated in the DIBBS solicitation portal.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Product Packaging and Labeling ServicesThe contract specifies the packaging, labeling, and barcode serialization of gutta-percha points to meet stringent military and medical standards, including DLA requirements, MIL-STD-129, and Medical Marking Standard No. 1. The work involves ensuring every unit is properly identified with accurate serial data, compliant labeling, and secure packaging to support traceability and inventory control within the Department of Defense supply chain. All processes must align with federal specifications for medical device marking and logistics documentation. This is a subcontract opportunity under NAICS code 325992, issued by the Department of Defense through the Medical Supply Chain FSH. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026. While no specific place of performance or point of contact is listed, the work is intended to support defense medical logistics and requires full compliance with DoD serialization and labeling protocols. Interested parties must access the official solicitation via the DIBBS portal at the provided URL to review full technical and administrative requirements.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

ESD/EMI Protective Packaging SupplyThe contract calls for the supply of ESD/EMI protective bags and wraps that meet MIL-PRF-81705 Type I and Type III specifications, requiring all materials to be sourced exclusively from manufacturers listed on the QPL-81705 qualified product list. The items must provide reliable electrostatic discharge and electromagnetic interference protection for sensitive electronic components, adhering strictly to military performance standards for durability, conductivity, and shielding effectiveness. All deliveries must be traceable to qualified vendors and comply with documented quality control requirements to ensure consistent protection in defense and aerospace applications. The procurement is issued as a subcontract under the Department of Defense’s Active Devices Division, with performance localized to Columbus, Ohio, and a final delivery deadline set for August 13, 2026. The NAICS code 325992 identifies the industry as Other Chemical Product and Preparation Manufacturing, indicating specialized formulation and production processes are involved. The solicitation is active as of August 2, 2026, and interested parties must submit responses before the stated deadline to be considered. While no set-aside designation is specified, the requirement is directed toward qualified suppliers capable of manufacturing to exacting defense specifications.

ACTIVE DEVICES DIVISION

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

GABAPENTIN CAPSULES

Solicitation # SPE2DP-26-T-4457

GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

TOLNAFTATE POWDER, U

Solicitation # SPE2DP-26-T-4452

The contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of 19 BT (each BT equaling 45 grams), supplied by Geri-Care Pharmaceuticals Corp. under part number NDC57896-0199-45 and NSN 6505014807897. Delivery is required within five days FOB destination, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and marking standards, including Medical Marking Standard No. 1, which replaces all references to MIL-STD-129, and must be packed in sealed unit containers and commercial shipping containers ensuring safe transport at the lowest carrier rate. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months. All packaging and labeling must adhere to DLA requirements outlined in the Master List of Technical and Quality Requirements, and covered defense information protocols apply. The solicitation, issued under SPE2DP-26-T-4452 with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett at Offutt AFB, and the unit of issue follows DoD authorization with corresponding ANSI X12 alignment.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4454

Lidocaine hydrochloride and dextrose injection in 500 mL premixed bags, containing 0.4% lidocaine and 5% dextrose, is being procured under solicitation SPE2DP-26-T-4454 with a unit of issue defined as a package of 18 bags. The item must meet stringent technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, and packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. At least 16 months of shelf life must remain at the time of delivery to the first government activity, as the product has a fixed 18-month non-extendable shelf life under Type I (Code K) requirements. The drug is regulated by the FDA, and contractors must ensure full compliance with all applicable federal standards for commercial packaging, including ASTM D3951 where applicable, though DLA requirements take precedence. The product is currently in limited supply due to manufacturing constraints, and only Baxter Healthcare Corp’s specific NDC 00338-0409-03 and part number 2B0973P are authorized. Delivery is required within five days of award, FOB destination, with zero variance permitted in quantity. The shipment must be sent via traceable and expedited means to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632, using RDD 777 and VSM logistics protocols, and parcel post is strictly prohibited. Packaging must be palletized according to RP001 requirements and labeled in full compliance with DLA’s medical marking standards. The contract specifies a single purchase request quantity of one package, with a required delivery date of August 5, 2026, and procurement is managed by the Department of Defense’s Medical Supply Chain PHARM FSA. All bidders must provide detailed manufacturer and product information for FDA verification through EBS referral prior to award.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

SODIUM CHLORIDE IRRIGA

Solicitation # SPE2DP-26-T-4449

Sodium Chloride Irrigation, USP, is prescribed as a 0.9% solution in 250 mL plastic squeeze bottles, packaged 24 bottles per packing group, and must be stored at controlled room temperature of 25 degrees Celsius with protection from excessive heat. The product must comply with the DLA Master List of Technical and Quality Requirements, and its shelf life is fixed at 36 months without extension, classified as a Type I (Code Q) item. All packaging and labeling must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, with documentation available via DLA Troop Support. Each unit must be sealed and protected from damage, and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to the designated destination. The item is identified by NSN 6505-01-253-8150 and NDC 00338-0048-02, supplied by Baxter Healthcare Corp, and is subject to a firm fixed price with zero variance allowed in quantity. Delivery is required FOB destination within five days of contract award, with inspection and acceptance occurring at the point of delivery. The contract is issued under solicitation SPE2DP-26-T-4449, with a response deadline of August 10, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. All data, including point of contact James Foggie and delivery location at Fort Bragg, NC, is governed by Federal procurement standards under the Department of Defense.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

BISMUTH SUBSALICYLA

Solicitation # SPE2DP-26-T-4459

The contract pertains to the procurement of Bismuth Subsalicylate Suspension, 262 mg per 15 mL, in 240 mL bottles, with a total order of two bottles. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of that shelf life may have elapsed between the date of manufacture and the date of delivery to the government. Packaging must comply with commercial standards and meet the requirements of Medical Marking Standard No. 1, which supersedes MIL-STD-129; each unit must be sealed in a container that protects against damage, and all shipping containers must ensure safe, cost-effective delivery via common carrier to the designated destination. The product is regulated by the FDA and requires referral through EBS for confirmation by a product specialist, including full manufacturer and bidder details. Labeling, marking, and packaging must adhere strictly to the latest edition of Medical Marking Standard No. 1, accessible via the DLA website. Delivery is FOB destination within 20 days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505015056483, NDC 00536-1286-36, and is sourced from The Harvard Drug Group, L.L.C. under solicitation SPE2DP-26-T-4459, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with performance at Fort Drum, NY.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-26-T-4455

The contract specifies the procurement of 20 packages of Artificial Tears Solution, each package containing 30 single-dose vials of 0.3 mL, for a total of 600 vials. The item is regulated by the FDA and has a non-extendable shelf life of 24 months, adhering to RS001 for TYPE I (CODE M) items. Packaging must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be hermetically sealed and protected against damage, packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost. The product, manufactured by Allergan Inc with NDC 00023-4554-30, must be labeled and marked per DLA specifications and is not considered hazardous under Fed-Std-313, requiring commercial packaging consistent with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Delivery is FOB destination within five days of order, with zero tolerance for quantity variance, and must be shipped by traceable means—parcel post is prohibited. The shipment is destined for USS THEODORE ROOSEVELT CVN 71, FPO AP 96632, with a required delivery date of August 5, 2026, and must include all applicable DLA packaging and labeling standards including palletization per RP001. The contracting official must submit an EBS referral for FDA confirmation, including manufacturer and product details.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4451

This contract specifies the procurement of 2 units of Lidocaine Hydrochloride and Epinephrine Injection, USP, each unit containing 50 cartridges of 1.7 mL with a concentration of 2% Lidocaine Hydrochloride and a 1:100,000 ratio of Epinephrine. The product is designated for local dental anesthesia via nerve block or infiltration only, must be stored at controlled room temperature below 25°C, protected from light, and must not be permitted to freeze. The item is latex-free and regulated by the FDA. A minimum of 13 months of remaining shelf life is required upon receipt by the first government activity, with a total shelf life of 15 months that is non-extendable. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be suitable for commercial shipping with protection against damage and breakage. Packaging must conform to ASTM D3951 unless otherwise overridden by DLA’s Master List of Technical and Quality Requirements, and hazardous material protocols under FED-STD-313 must be followed if applicable. Units are packed as 50 cartridges per unit of issue (PG), and palletization must meet DLA’s procurement packaging standards. Delivery is required FOB destination within 20 days of contract award to Joint Base Charleston, SC, and must be shipped via traceable logistics—parcel post is prohibited. The contract is issued under solicitation SPE2DP-26-T-4451 with a response deadline of August 10, 2026, and the item’s NSN is 6505-01-597-1328. Approved manufacturers include Henry Schein, Inc., Benco Dental Supply Co., and Darby Dental Supply, LLC, with specific part and NDC numbers listed. All documentation and labeling must strictly adhere to DLA requirements and FDA regulations.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

MAGNESIUM SULFATE

Solicitation # SPE2DP-26-T-4456

MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.

Medicinal and Botanical Manufacturing

POSTED

about 14 hours ago

DEADLINE

CYCLOSPORINE OPHTHA

Solicitation # SPE2DP-26-T-4453

Cyclosporine Ophthalmic Ointment, 0.2% per gram, in a 3.5 gram sterile, preservative-free tube, is designated for veterinary use in managing keratoconjunctivitis sicca in dogs. The unit of issue is a package containing six tubes, and the product must be stored at controlled room temperature. It is subject to strict packaging standards per the latest Medical Marking Standard No. 1 and requires marking in accordance with MMS No. 1B dated 30 March 2017. The item has a non-extendable shelf life of 24 months under RS016 compliance. The product is supplied by multiple manufacturers including Merck Sharp & Dohme LLC, Patterson Veterinary Supply, Inc., and Penn Veterinary Supply Inc., each with their respective part numbers and NDC codes. This item is procured under the Department of Defense with NSN 6509-01-530-4765 and purchase request 7017723033, with a contract solicitation number SPE2DP-26-T-4453. Delivery is scheduled for 89 days after award, FOB destination, with zero variance permitted in quantity, and inspection and acceptance occur at the destination. Packaging must meet MIL-STD-2073-1E specifications, and defense information handling requirements apply. The point of contact for the solicitation is Shairy M. Cartagena at the Medical Supply Chain Pharm FSA under the DLA.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

WATER PURIFICATION TAB

Solicitation # SPE2DP-26-T-4448

The contract specifies the procurement of 200 units of water purification tablets containing stabilized chlorine dioxide, with no active chlorine or iodine, designed for military use in first aid kits. Each unit, designated as PG, contains ten individually sealed tablets and must meet a strict 60-month shelf life, with at least 51 months remaining upon delivery to the government. The product, identified by NSN 6850-01-530-3396 and part number 8014821 from KATADYN NORTH AMERICA INC., is subject to the Hazard Communication Standard as revised under OSHA’s alignment with the Globally Harmonized System, requiring suppliers to submit approved Safety Data Sheets and compliant labels prior to award, along with employee training on updated hazard communication protocols. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and comply with MIL-STD-2073-1E for protective sealing and shipping containers suitable for common carrier transport at the lowest cost to the destination point of APO with ZIP 96260-5479. Delivery is required within 84 days FOB destination, with zero tolerance for quantity variance, and inspection and acceptance occur at the point of delivery. The item is classified as a TYPE I (CODE S) under shelf-life requirement RS001, which prohibits extension beyond the 60-month limit. All technical and quality requirements referenced are governed by the DLA Master List, and the solicitation number SPE2DP-26-T-4448 governs procurement terms under a federal acquisition vehicle.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

WATER FOR IRRIGATION, S

Solicitation # SPE2DP-26-T-4458

Water for Irrigation, Sterile, USP, is a sterile, distilled, nonpyrogenic solution intended exclusively for irrigation, washing, rinsing, and dilution purposes and is not for injection by any parenteral route. Each unit is a 1000 mL semi-rigid plastic container with a screw cap, available with or without a hanging device, and is packaged in cases of 12 units per package, the unit of issue. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, and has a non-extendable shelf life of 36 months. It is regulated by the FDA and must be marked in compliance with the latest edition of Medical Marking Standard No. 1 and labeled according to MIL-STD-129. Packaging must adhere to DLA’s RP001 requirements and ASTM D3951 for non-hazardous materials, with DLA’s technical and quality requirements overriding any conflicting standards. The item is identified by NSN 6505-01-075-0679 and NDC 00338-0004-04, manufactured by Baxter Healthcare Corporation. The contract specifies delivery of two packages totaling 24 units, with delivery due within 20 days to two separate destinations: USS William P Lawrence DDG 110 and USS Zumwalt DDG 1000, FOB destination. Inspection and acceptance occur at the delivery point, with zero variance permitted in quantity. Shipping must use traceable transport methods, and parcel post is prohibited. All requirements, including those from the DLA Master List of Technical and Quality Requirements, must be strictly followed, and the solicitation, issued by the Department of Defense, has a response deadline of August 10, 2026, with a contract award anticipated in support of military medical supply needs.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-26-T-4450

RINGER’S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per package, is procured under contract SPE2DP-26-T-4450 with a delivery requirement of 20 days FOB destination. The item is regulated by the FDA and requires prior confirmation by a product specialist through EBS referral, including full bidder and manufacturer details such as B. BRAUN MEDICAL INC, part number L7500, and NDC 00264-7750-00. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest cost. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be marked according to the latest edition of MMS NO. 1, accessible via DLA’s website. The product has a non-extendable shelf life of 30 months and must be stored at or near room temperature (25°C), with brief exposure to 40°C permitted without degradation. Inspection and acceptance occur at the destination, with zero tolerance for quantity variance. The unit of issue is one package (PG), equal to 12 units, and the NSN is 6505013306267. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. Delivery is to Gastonia, NC, and the contracting office is under the Department of Defense’s Medical Supply Chain.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE